534.47 USD
↘ 4.41 (0.82%)LIVE (AS OF 09:35 AM EDT)
Madrigal Pharmaceuticals, Inc. Common Stock
MDGLNASDAQ • USD
Market: OPEN
Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) is currently trading at $534.47. The technical outlook is "Strong Buy" and the fundamental picture shows "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Aug 26, 2026.
Open?$538.00
High?$540.66
Low?$529.95
Prev. Close?$538.88
Volume?1.4K
Avg. Volume?345.5K
VWAP?$537.66
Rel. Volume?0.00x
Bid / Ask
Bid?$507.30 × 40
Ask?$577.50 × 40
Spread?$70.20
Midpoint?$542.40
Valuation & Ratios
Market Cap?12.5B
Shares Out?23.1M
Float?16.5M
Float %?71.7%
P/E Ratio?N/A
P/B Ratio?23.77
EPS?-$14.07
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
Employees
915
Market Cap
12.5B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2007-02-06
Address
1001 CONSHOHOCKEN STATE ROAD
WEST CONSHOHOCKEN, PA
Phone: (267) 824-2827
WEST CONSHOHOCKEN, PA
Phone: (267) 824-2827
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?100
Momentum?62
Short Sent.?34
Piotroski F-Score?1/9Weak
Altman Z-Score?8.81Safe
Confidence?58%Low
Short InterestHigh
Short % of Float?12.25%High
Short Interest?2.0M
Days to Cover?6.1
Free Float16.5M
Avg Daily Volume335.0K
Settlement Date2026-08-14
Financial Health
Current Ratio?3.20Strong
Quick Ratio?2.94Strong
Cash Ratio?0.78Adequate
Debt/Equity?0.65Moderate
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score50/100
P/E?N/A▾
P/B?23.77HIGH▾
Peers100
S&P3
P/S?9.70HIGH▾
Peers100
S&P9
P/FCF?N/A▾
EV/EBITDA?-38.9CHEAP▾
S&P97
EV/Sales?9.73HIGH▾
Peers100
S&P11
Returns & Efficiency
ROE?-62.1%WEAK▾
S&P3
ROA?-26.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-206285000
Enterprise Value?$12.5B
Fundamentals ratios updated end of day